Artificial Lumbar Disc Trial Results Could Make SpineCore Acquisition Target
This article was originally published in The Gray Sheet
Executive Summary
SpineCore will begin a randomized, multi-site U.S. clinical trial for its FlexiCore intervertebral disc this month under a July 25 FDA investigational device exemption
You may also be interested in...
Third-Party Payor Clinical Trial Reimbursement Requires Persistence – Exec
Enlisting primary site investigators to contact third-party payors can aid in securing clinical trial reimbursement, according to Medtronic Sofamor Danek Reimbursement Group Director Robert Peterson
Third-Party Payor Clinical Trial Reimbursement Requires Persistence – Exec
Enlisting primary site investigators to contact third-party payors can aid in securing clinical trial reimbursement, according to Medtronic Sofamor Danek Reimbursement Group Director Robert Peterson
Degenerative Disc R&D Heats Up: Biorthex Evaluates Cervical Fusion Device
Biorthex' recent IDE for the Actipore ACF places the Montreal-based firm with Medtronic and Synthes-Stratec in developing cervical implant approvals for the U.S. market